RISK WARNING: Your capital is at risk. The risks include: the lack of liquidity in this market in terms of being able to realise investments and the loss of the value of investment. When you invest any loss in value will not be covered by the Financial Services Compensation Scheme.
Please read FULL risk warning.
Cambridge Medical Technologies Limited
CMT has developed a lab-on-a-chip on a Band-Aid that continuously and imperceptibly monitors certain blood biomarkers present in intercellular fluid j
A pledge is not a commitment. You will be asked to confirm in the next section.
This company has not shared it's twitter feed.
Originator: Cambridge Medical Technologies
Deal Type: Equity
Geographical Focus: UK, Europe, and China
About: Cambridge Medical Technologies Limited (CMT), has designed an electronic chip that imperceptibly conducts tests for blood biomarkers and wirelessly communicates the results to physicians, enabling the real time monitoring of trends relating to medical condition - regardless of patient location.
Type: Company raising finance
Contact Name: James Cooke
Date established: September 2014
Date Joined Envestry: February 2019